Earnings Summary

Kronos Bio Inc’s revenue jumped +Inf% since last year same period to $1.86Mn in the Q2 2023. On a quarterly growth basis, Kronos Bio Inc has generated 52.66% jump in its revenue since last 3-months.

Kronos Bio Inc’s net profit jumped 9.61% since last year same period to $-29.74Mn in the Q2 2023. On a quarterly growth basis, Kronos Bio Inc has generated -13.35% fall in its net profits since last 3-months.

Kronos Bio Inc’s net profit margin jumped NaN% since last year same period to -1595.55% in the Q2 2023. On a quarterly growth basis, Kronos Bio Inc has generated 25.75% jump in its net profit margins since last 3-months.

Kronos Bio Inc’s earning per share (EPS) estimates for the current quarter stand at -0.62 - a 4.62% jump from last quarter’s estimates.

Kronos Bio Inc’s earning per share (EPS) estimates for the current year stand at -0.62.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Kronos Bio Inc’s return on assets (ROA) stands at -0.27.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Kronos Bio Inc’s return on equity (ROE) stands at -0.48.